Dexcom Inc at JPMorgan Healthcare Conference Transcript
Hello, everyone. I'm Robbie Marcus, the med tech analyst at JPMorgan. Thanks for joining here before lunch. Happy to have our next company, Dexcom. I'm going to introduce the CEO, Kevin Sayer for a presentation, and then we'll do some Q&A after. Kevin?
Thank you, Robbie, and thank you everyone for coming today.
For those of you who know me, I've been in the diabetes business since 1994. That's when I saw my first glucose sensor. It was hardwired and attached to something that looked like a crude high school basketball scoreboard and dipped in a beaker of glucose solution. It showed the number and I thought the technology was done. My little naive financial mind wasn't quite where it was supposed to be because it's taken a long time to get where we are today, but oh how things have changed. Back then all we wanted to do is display that data on a pump. Now we display that data on a phone and it goes to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |